Tissue Valve Degeneration and Mechanical Valve Failure

Area of Science:

• Cardiovascular Medicine
• Biomedical Engineering
• Surgical Innovation

Background:

• Aging populations increase the prevalence of valvular heart disease and the need for prosthetic valve management.
• Understanding prosthetic valve behavior and durability is essential for patient selection and clinical decision-making.
• Structural valve degeneration (SVD) and failure are significant concerns in patients with artificial heart valves.

Purpose of the Study:

• To provide a comprehensive overview of SVD, including its definitions, underlying mechanisms, and clinical impact.
• To review current management strategies and emerging technologies for SVD.
• To highlight the importance of patient-specific valve selection and risk reduction.

Main Methods:

• Literature review of published studies on prosthetic valve behavior and durability.
• Analysis of definitions, outcome measures, and pathophysiological factors contributing to SVD.
• Evaluation of technological advancements and clinical strategies for mitigating SVD risks.

Main Results:

• Variable definitions and outcome measures complicate the understanding of bioprosthetic valve function.
• SVD is multifactorial, involving mechanical, hematologic, and immunologic processes.
• Mechanical valves show high durability, while bioprosthetic valves require careful consideration of degeneration risks and potential reintervention.
• Technological advancements improve valve performance and offer new mitigation strategies.

Conclusions:

• Bioprosthetic valve selection requires patient-specific deliberation, guided by established risk reduction strategies.
• Surgical valve replacement is the standard for prosthetic valve failure.
• Emerging technologies and transcatheter valve-in-valve procedures show promise for managing SVD and improving long-term outcomes.